Clinical Trial: A prospective clinical study of Sacituzumab Tirumotecan combined with Pembrolizumab in the treatment of advanced biliary tract cancer (China)

Posted On: 2026-09-21

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective clinical study of Sacituzumab Tirumotecan combined with Pembrolizumab in the treatment of advanced biliary tract cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132859

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337172

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A prospective clinical study of Sacituzumab Tirumotecan combined with Pembrolizumab in the treatment of advanced biliary tract cancer (China)